A RAPID RESULT OF REVACCINATION.
نویسندگان
چکیده
منابع مشابه
Revaccination and Duration of Protection
Pneumococcal polysaccharide vaccine induces an initial rise in ELISA antibody levels, which then decline over time and in older adults antibody levels measured 4 to 7 years post-vaccination tend to approximate pre-vaccination baseline levels (1-5). The clinical significance of this decline is not well defined, as immune correlates of protection for pneumococcal vaccine in adults have not been e...
متن کاملA SHORT PROOF OF A RESULT OF NAGEL
Let $(R,fm)$ be a Gorenstein local ring and$M,N$ be two finitely generated modules over $R$. Nagel proved that if $M$ and $N$ are inthe same even liaison class, thenone has $H^i_{fm}(M)cong H^i_{fm}(N)$ for all $iIn this paper, we provide a short proof to this result.
متن کاملFrequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.
In 2008, potential temperature compromise of one lot of trivalent inactivated influenza vaccine (TIV) led to the revaccination of 13,210 Kaiser Permanente Northwest members within 28 days of receipt of their initial TIV dose. We conducted a retrospective cohort study to determine if these individuals experienced a higher rate of medically attended events (MAE) than those receiving only one TIV ...
متن کامل[BCG revaccination in schoolchildren: a pioneer study].
* Professor Adjunto do Departamento de Pediatria da Faculdade de Medicina da Universidade Federal do Rio de Janeiro (UFRJ). Presidente do Departamento Científico de Pneumologia da SBP. O primeiro de julho é o Dia da Vacina BCG. O fato de existir uma data comemorativa para a vacina demonstra a sua importância na história da humanidade. Essa vacina encerra inúmeras controvérsias desde que foi emp...
متن کاملFrequency of Revaccination against Smallpox
extending the time for revaccination beyond 10 years may be based on insufficient and conflicting evidence of persistence of immunity (1,2). The evidence that cellmediated immunity and neutralizing antibody persist after one vaccination is conflicting (2–5). This residual immunity is often low, and its protective activity in vivo is unclear. Similarly, in vivo reports of durable immunity to sma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1900
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(01)97277-0